Cargando…
Revitalizing hope for older adults: The use of the novel Arexvy for immunization against respiratory syncytial virus
INTRODUCTION: Respiratory syncytial virus (RSV), an RNA virus of the family Paramyxoviridae, is the most common cause of respiratory tract diseases, including upper and lower respiratory tract infections in adults. Researchers worldwide have been working for decades to develop an RSV vaccine that is...
Autores principales: | Abbasi, Haleema Q., Oduoye, Malik O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617982/ https://www.ncbi.nlm.nih.gov/pubmed/37916140 http://dx.doi.org/10.1002/hsr2.1648 |
Ejemplares similares
-
Respiratory syncytial virus: paying the immunity debt with interest
por: Hatter, Lee, et al.
Publicado: (2021) -
Advancing precision oncology in breast cancer: the FDA approval of elacestrant and Guardant360 CDx: a correspondence
por: Abbasi, Haleema Qayyum, et al.
Publicado: (2023) -
COVID-19 public health measures and respiratory syncytial virus
por: Britton, Philip N, et al.
Publicado: (2020) -
Influenza and respiratory syncytial virus interbreed: Engendering a novel deadly virus
por: Amin, Ruhul, et al.
Publicado: (2023) -
Whole blood gene expression in infants with respiratory syncytial virus bronchiolitis
por: Fjaerli, Hans-Olav, et al.
Publicado: (2006)